Toyobo Co., Ltd.
Stock Price Chart
2026/03/13 UpdatedPrice Trend
2026/03/13 UpdatedPrice & Trading Details
2026/03/13 UpdatedPRICE
TRADING
Analyst Recommendations 3 analysts
Updated 2026/03/01Shareholder Composition
Updated 2026/03/01Dividend History
Updated 2026/03/15| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥40 | 0.0% |
| 2024 | ¥40 | 0.0% |
| 2023 | ¥40 | 0.0% |
| 2022 | ¥40 | 0.0% |
| 2021 | ¥40 | - |
Financial Performance
2026/03/15 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥375,720M | ¥399,921M | ¥414,265M | ¥422,032M |
| Gross Profit | ¥96,126M | ¥85,006M | ¥87,998M | ¥97,055M |
| Operating Income | ¥28,430M | ¥10,063M | ¥8,995M | ¥16,653M |
| Pretax Income | ¥16,007M | ¥1,940M | ¥6,942M | ¥9,350M |
| Net Income | ¥12,865M | -¥655M | ¥2,455M | ¥2,003M |
| EPS | ¥144.75 | -¥7.37 | ¥27.87 | ¥22.73 |
| Operating Margin | 7.57% | 2.52% | 2.17% | 3.95% |
| Balance Sheet | ||||
| Total Assets | ¥517,774M | ¥588,906M | ¥606,990M | ¥617,799M |
| Total Equity | ¥194,876M | ¥189,589M | ¥197,032M | ¥195,312M |
| Total Liabilities | ¥322,898M | ¥399,317M | ¥409,958M | ¥422,487M |
| Cash | ¥27,176M | ¥60,703M | ¥33,796M | ¥28,581M |
| Interest-bearing Debt | ¥187,691M | ¥225,166M | ¥242,091M | ¥261,070M |
| Equity Ratio | 37.64% | 32.19% | 32.46% | 31.61% |
| D/E Ratio | 0.96 | 1.19 | 1.23 | 1.34 |
| Cash Flow | ||||
| Operating CF | ¥17,097M | ¥7,798M | ¥21,595M | ¥30,118M |
| Investing CF | -¥24,608M | -¥36,011M | -¥58,784M | -¥46,386M |
| Financing CF | -¥1,729M | ¥61,295M | ¥8,260M | ¥10,490M |
| Free CF | -¥12,015M | -¥31,360M | -¥35,034M | -¥15,107M |
| Efficiency | ||||
| ROE | 6.60% | -0.35% | 1.25% | 1.03% |
| ROA | 2.48% | -0.11% | 0.40% | 0.32% |
Latest IR Information
-
No IR information found for this company.
Searched stock code: 3101
Latest News (5 items)
-
Average Analyst Rating: buy
Average Target Price: ¥1,883
Rating Score: 1.67 (Based on 3 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Toyobo Co., Ltd. provides films and functional polymers, industrial materials, and healthcare and textile products worldwide. The company operates through the following segments: Films, Life Science, Environmental and Functional Materials, Functional Textiles, and Trading and Real Estate. The Films segment manufactures and sells packaging films, including PET, polyolefin, and nylon for food packaging, as well as heat-resistant PET films; industrial films, such as PET films for liquid crystal displays, optical uses, and other industrial applications, as well as synthetic papers and other products. The Life Science segment manufactures and sells bio-products, such as enzymes for diagnostics, pharmaceuticals, medical membranes, medical devices, and other products, as well as artificial kidney hollow fibers and seawater desalination membranes. The Environmental and Functional Materials segment manufactures and sells engineering plastics, industrial adhesives, photo-functional materials, water treatment membranes, functional filters, high-performance fibers, nonwoven fabrics, and other products. The Functional Textiles and Trading segment manufactures and sells airbag fabrics, functional textiles, apparel products, apparel textiles, apparel fibers, and other products. The Real Estate segment leases and manages real estate properties and others. Toyobo Co., Ltd. was founded in 1882 and is headquartered in Osaka, Japan.
